The cost and duration of clinical trials have escalated dramatically in the past 20 years, hampering introduction of new therapies and limiting people's access to high-quality clinical research.
The US Food and Drug Administration has released a five-part action plan for its oversight of artificial intelligence/machine learning (AI/ML)-based software as a medical device (SaMD) based on ...
The cost and duration of clinical trials have escalated dramatically in the past 20 years, hampering introduction of new therapies and limiting people's access to high-quality clinical research.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results